CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-23 | Fenimore Christopher R. SVP Controller | Option exercise · Non-Qualified Stock Option (right to buy) | −7,000 | 10,000 | ||
| 2023-08-23 | Landry Robert E EVP Finance CFO | Sale | −223 | $844.00 | $188K | 31,699 |
| 2023-08-23 | POON CHRISTINE A Director | Option exercise | +12,280 | $273.67 | $3.4M | 14,317 |
| 2023-08-23 | POON CHRISTINE A Director | Sale | −300 | $837.92 | $251K | 14,017 |
| 2023-08-23 | POON CHRISTINE A Director | Sale | −1,998 | $838.60 | $1.7M | 12,019 |
| 2023-08-23 | POON CHRISTINE A Director | Sale | −3,032 | $839.45 | $2.5M | 8,987 |
| 2023-08-23 | POON CHRISTINE A Director | Sale | −6,450 | $840.65 | $5.4M | 2,537 |
| 2023-08-23 | POON CHRISTINE A Director | Sale | −500 | $841.05 | $421K | 2,037 |
| 2023-08-23 | POON CHRISTINE A Director | Option exercise · Non-Qualified Stock Option (right to buy) | −12,280 | 0 | ||
| 2023-08-23 | Van Plew Daniel P EVP & General Mgr, Industrial | Option exercise | +23,125 | $381.40 | $8.8M | 44,633 |
| 2023-08-23 | Van Plew Daniel P EVP & General Mgr, Industrial | Shares withheld for taxes | −16,928 | $842.66 | $14.3M | 27,705 |
| 2023-08-23 | Van Plew Daniel P EVP & General Mgr, Industrial | Option exercise · Non-Qualified Stock Option (right to buy) | −23,125 | 23,125 | ||
| 2023-08-22 | STAHL NEIL EVP Research and Development | Sale | −6,309 | $840.53 | $5.3M | 58,456 |
| 2023-08-22 | STAHL NEIL EVP Research and Development | Sale | −4,574 | $841.41 | $3.8M | 53,882 |
| 2023-08-22 | STAHL NEIL EVP Research and Development | Sale | −782 | $842.16 | $659K | 53,100 |
| 2023-08-21 | STAHL NEIL EVP Research and Development | Option exercise | +50,000 | $399.66 | $20.0M | 103,100 |
| 2023-08-21 | STAHL NEIL EVP Research and Development | Shares withheld for taxes | −38,335 | $833.39 | $31.9M | 64,765 |
| 2023-08-21 | STAHL NEIL EVP Research and Development | Option exercise · Non-Qualified Stock Option (right to buy) | −50,000 | 30,750 | ||
| 2023-08-21 | Bassler Bonnie L Director | Option exercise 10b5-1 | +853 | $391.92 | $334K | 2,100 |
| 2023-08-21 | Bassler Bonnie L Director | Sale 10b5-1 | −853 | $829.00 | $707K | 1,247 |
Page 50 of 105 · 2,088 trades